Device Trial Radar · NCT00590889
Artificial Valve Endocarditis Reduction Trial
Last checked: Nov 20, 2026Latest source record: Feb 27, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
807
Actual
Start
Jul 1998
Primary completion
Sep 2014
Study completion Sep 2014
Sponsor
- Lead sponsor
- Abbott Medical DevicesPublic (ABT)
- Sponsor type
- Industry
- Collaborators
- University of Pittsburgh
- First posted
- Jan 11, 2008
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to investigate whether the Silzone coated sewing cuff reduces the incidence of prosthetic valve endocarditis (PVE).
Conditions
- Aortic Valve Disease
- Mitral Valve Disease
- Endocarditis
Interventions
Artificial Mechanical Heart ValveDevice
Both arms used market released mechanical heart valves in accordance with approved labeling
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Prosthetic Valve Endocarditis Comparing Conventional Valves to Silzone™ Coated Valves.Time frame: 1 year
Locations
16 sites in 8 countries. Site status is shown where the registry gives one.
Florida Heart Group
Orlando, Florida
Massachusetts General Hospital
Boston, Massachusetts
Brigham and Womens Hospital
Boston, Massachusetts
13 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.